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ABSTRACT
Mitochondrial dysfunction plays critical roles in
cancer development and related therapeutic re-
sponse; however, exact molecular mechanisms re-
main unclear. Recently, alongside the discovery
of mitochondrial-specific DNA methyltransferases,
global and site-specific methylation of the mito-
chondrial genome has been described. Investiga-
tion of any functional consequences however re-
mains unclear and debated due to insufficient evi-
dence of the quantitative degree and frequency of
mitochondrial DNA (mtDNA) methylation. This study
uses WGBS to provide the first quantitative report
of mtDNA methylation at single base pair resolu-
tion. The data show that mitochondrial genomes are
extensively methylated predominantly at non-CpG
sites. Importantly, these methylation patterns dis-
play notable differences between normal and can-
cer cells. Furthermore, knockdown of DNA methyl-
transferase enzymes resulted in a marked global
reduction of mtDNA methylation levels, indicating
these enzymes may be associated with the estab-
lishment and/or maintenance of mtDNA methylation.
DNMT3B knockdown cells displayed a comparatively
pronounced global reduction in mtDNA methylation
with concomitant increases in gene expression, sug-
gesting a potential functional link between methy-
lation and gene expression. Together these results
demonstrate reproducible, non-random methylation
patterns of mtDNA and challenge the notion that
mtDNA is lowly methylated. This study discusses key
differences in methodology that suggest future in-
vestigations must allow for techniques that assess
both CpG and non-CpG methylation.
INTRODUCTION
Mitochondria maintain cellular homeostasis by generating
metabolic energy via oxidative phosphorylation (OXPHOS)
as well as regulating apoptotic pathways. Mitochondrial
dysfunction in a wide range of human malignancies is well
documented and targeting mitochondria remains a promis-
ing avenue for the development of novel strategies for cancer
treatment (1).
Mitochondrial DNA (mtDNA) is a double helical
molecule composed of a heavy and light strand that encodes
for 13 protein subunits thatmake up the complexes required
for OXPHOS, transfer RNAs that carry specific amino
acids for protein synthesis as well as ribosomal RNAs also
involved in protein synthesis (2). A 1200-bp non-coding
region of the mitochondrial genome, called the Displace-
ment Loop (D-Loop), controls mitochondrial replication
and transcription of its encoded genes (2) through a num-
ber of different start sites and promoter regions (3–5). How-
ever, exact molecular mechanisms involved in transcrip-
tional control of the mitochondrial genome remain unclear.
The existence of mtDNA methylation has been reported
previously via a large array of techniques, while some stud-
ies have reported an absence of mtDNA methylation (6,7),
the majority have detected it (8–11). Older studies reported
human fibroblast cultures and cell lines to have 2–5% of
all mtDNA molecules fully methylated at specific CpG re-
gions analysed via the method involving restriction diges-
tion (12). Similar findings were reported using radioactive
labelling in mouse fibroblast and hamster kidney cell cul-
tures (13). Later studies confirmed the presence of mtDNA
methylation in mouse brain tissue using ELISA (14), in
lymphoblastoid cells of Down Syndrome children using
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mass spectrometry (15) as well as in human colorectal can-
cer cell lines (10) and human brain tissue (16) using im-
munoprecipitation. Pyrosequencing and bisulfite sequenc-
ing have also detected site specific mtDNA methylation
in human blood cells (17–19). In addition, methylation-
specific PCR techniques have detected substantial mtDNA
methylation in liver tumour samples (11). Furthermore, the
biological relevance of mtDNA methylation was suggested
by a study showing that DNMT1 contains a targeted se-
quence upstream of its TSS that allows translocation into
the mitochondria where it binds to the D-Loop (10). Ele-
vated levels of DNMT1 correlated with increased expres-
sion of some mitochondrial genes adding weight to the
notion that DNMT1 may have functional capacity in the
mitochondria (10). Recently, DNMTIso3 (an isoform of
DNMT1) was shown to be more concentrated in the mi-
tochondria than DNMT1; suggesting that certain isoforms
of DNA methyltransferases are mitochondria specific (20).
Two independent studies reported the presence of DNMT1,
DNMT3A and DNMT3B enzymes in the mitochondrial
protein fraction of mouse skeletal muscle (21) and mouse
embryonic stem cells (17). Finally, a more recent study uti-
lized CpG andGpCmethyltransferases to target mitochon-
drial DNA and concluded that increased GpC methyla-
tion decreased the abundance of mitochondrial encoded
transcripts (22). Collectively these findings suggest the ex-
istence of mtDNA methylation, which may have a biolog-
ical relevance, however mtDNA methylation remains de-
bated largely due to contradictory reports from bisulfite se-
quencing studies (6,23). Since a genome-wide quantitative
approach has not been demonstrated successfully for com-
prehensive mapping of mtDNA methylation patterns, ex-
ploration of the biological relevance of mtDNA methyla-
tion remains impeded.
Recently, several reports in the field aimed at improv-
ing techniques to be used for identification of mtDNA
methylation however these studies focused primarily on
CpG methylation (23–26). The present study builds on
those findings by addressing key methodological adapta-
tions which are required for investigating mtDNA methy-
lation via whole genome bisulfite sequencing. This study
presents the first report of genome-wide mitochondrial
DNAmethylation across different cell lines and tissue sam-
ples at single nucleotide resolution. The results show non-
random, reproducible patterns of mtDNAmethylation pre-
dominantly in a non-CpG context. Differences in global
methylation for normal versus cancer cells derived from
both liver and breast cancer are observed. Finally, the data
implicates DNMT1, DNMT3A and DNMT3B to be asso-
ciated with mtDNA methylation.
MATERIALS AND METHODS
Cell line selection
Normal breast epithelial cells MCF10A were maintained
in DMEM (Invitrogen No. 11039-047) with 10% FBS, 1%
penicillin-streptomycin, 20 ng/ml epidermal growth factor
(Peprotech 1 mg), 0.5 g/ml hydrocortisone (Sigma No. H-
0888), 100 ng/ml cholera toxin (Sigma No. C-8052) and
10 g/ml insulin (Sigma No. I-1882). Human breast can-
cer cells MCF7 were maintained in DMEM (Invitrogen
No. 11039-047) with 10% FBS, 1% penicillin-streptomycin,
sodium pyruvate (1 mM) and glutamine (2 mM). Hu-
man hepatocarcinoma cells HepG2 were maintained in
DMEM (Invitrogen No. 11039-047) with 10% FBS and 1%
penicillin-streptomycin. All cells were maintained in an at-
mosphere of 5% CO2 at 37◦C. Frozen pellets of primary de-
rived human breast cancer cells (HMEC) were a gift from
the Jiri Zavadil’s lab and primary human hepatocytes were a
gift from Prof. Michel Rivoire - Centre Le´on Be´rard (CLB),
INSERM U1032, Lyon, France.
Mitochondrial DNA extraction
Frozen cell pellets (1× 107 cells) were resuspended in 500l
ice-cold homogenization buffer (100 mM Tris-HCl pH 7.4,
250mMsucrose, 10mmMEDTA) on ice. The cell pellet was
homogenized with a 30G syringe and centrifuged (Eppen-
dorf Centrifuge 5424 R) at 4◦C, 1500 g for 10 min to collect
debris. The supernatant was then transferred to a new tube
and centrifuged again at 4◦C, 10 000 g for 10 min. The pel-
let containing mitochondria was resuspended in 50 l high-
salt buffer (10 mM Tris-HCl pH 7.6, 10 mM KCl, 10 mM
MgCl2, 0.4MNaCl, 2 mMEDTA). About 8l of 10% SDS
was then added to the homogenate and the homogenate
was incubated for 7 min at 55◦C to denature and solubilize
proteins. Proteins were then removed by addition of 20 l
of 5 M NaCl and centrifugation at 11 300 g for 20 min
at room temperature. The supernatant was collected into
a new 1.5 ml Eppendorf tube. Twice the volume of 100%
ethanol was added and the supernatant was centrifuged for
10 min at 10 000 g for precipitation of the mtDNA pel-
let. The pellet was resuspended in 50 l of milliQ H20 and
immediately processed with phenol-chloroform method for
clean-up. An equal volume of phenol/chloroform/isoamyl
alcohol (25:24:1) was added and sample was mixed gen-
tly by inverting the tube. The tube was then centrifuged at
room temperature for 5 min at 12 000 g. The top aqueous
layer was carefully collected and the same process was re-
peated with chloroform/isoamyl alcohol (24:1). To the up-
per aqueous layer, collected in a fresh tube, 1/10th volume
of 3 M NaOAc (pH 5.2), 2 l glycogen (15 mg/ml Am-
bion) and 2.5× volume of absolute ethanol was added and
mixed by gently inverting the tube. The mixture was incu-
bated overnight at −20◦C or for 2 h at −80◦C. The crude
mitochondrial pellet was obtained by centrifugation at 4◦C
for 15 min, 12 000 g. The pellet was resuspended in 20 l
MilliQ grade H20 and concentration of mtDNA was as-
sessed using Qubit fluorometer.Multiple pellets of the same
cell type were processed this way and mtDNA was pooled
until a minimum 2 g concentration was achieved for bisul-
fite modification.
DNA quality check
Relative enrichment of mtDNA to nuclear DNA of all ex-
tractions was assessed with qPCR to ensure the extractions
were not contaminated with nuclear DNA. Primers specific
to the mitochondrial genome, Forward Primer (5′-GCTC
AACACCCACTACCTAAA-3′), Reverse Primer (5′-TG
ATCTGACGCAGGCTTATG-3′) as well as primers spe-
cific to nuclear encoded gene GAPDH, Forward Primer (5′-
CCCTTCATACCCTCACGTATTC-3′), Reverse Primer
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(5′-CCATTCTGTCTTCCACTCACTC-3′) were used to
amplify the mtDNA extraction. The quality of the extrac-
tion was assessed by comparing the fold change of mito-
chondrial genome versus nuclear genome using the Ct
method.
Mitochondrial DNA pre-processing
Linearization of 700 ng of HepG2 mtDNA was achieved
via a 10-min incubation of mtDNA at 65 degrees to en-
courage uncoiling followed by a 9-h incubation with 2U of
BamHI restriction enzyme and NEB Buffer. Linearization
was confirmed by visualization on 1% Agarose gel. Subse-
quently, sonication was selected as a better method since
this has been shown to improve library preparation quality
specifically for NGS in the context of plasmid DNA (27).
Since mtDNA is of a similar structure to plasmid DNA,
all mtDNA samples were sonicated with the Diagenode
bioruptorNextGen until fragments between 100 and 10 000
bp was achieved. MtDNA from each cell type was diluted
to an appropriate concentration determined experimentally
and sonicated with different conditions ranging from 3 cy-
cles on the HIGH setting to 25 cycles on HIGH setting
with a sonication time of 30 s per cycle. Fragment sizes of
HepG2 cells were initially assessed on the BioAnalayser as
well as 1% Agarose gel to confirm the method works. All
other samples were subsequently checked on 1% Agarose
gel to ensure no visible secondary structure remained. The
mtDNA was then bisulfite modified using the EZ DNA
Methylation Gold Kit (Zymo Research, USA), and the
bisulfite modified DNA was quantified on Nano Drop us-
ing the ssDNA setting.
Pyrosequencing
Bisulfite modified DNAwas amplified with previously pub-
lished pyrosequencing primers ((19); Supplementary Table
S1) in a 50 l reaction. Following visualization of ampli-
con via gel agarose, 45 l of PCR product was used with
the PyroMark Kit (QIAGEN Cat. No. 972804) for each se-
quencing reaction as per manufacturer instructions. Briefly,
DNA was immobilized on to streptavidin-coated beads in
binding buffer for 10 min. The biotin-labeled template was
purified using the pyrosequencing vacuum prep tool and
incubated with 10 pmol/reaction sequencing primer in an-
nealing buffer (20 mMTris-acetate, 2 mMMgAc2; pH 7.6).
The DNA strands were denatured at 80◦C for 2 min and re-
annealed at room temperature for 10 min. Sequencing was
performed according to manufacturer instructions.
Library preparation and next-generation sequencing
Library preparation of the extracted, phenol-chloroform
cleaned, sonicated and bisulfite modified mtDNA was then
performed using the TruSeq DNA Methylation Kit (Illu-
mina, EGMK81312) according to manufacturer instruc-
tions. Briefly, 200 ng of bisulfite-converted mtDNAwas lig-
ated to adapters and amplification indexes from the TruSeq
Indexes Kit (Illumina) were introduced during PCR ampli-
fication. Adapter-Tagged libraries were purified using AM-
Pure beads (Beckman Coulter). Libraries were assessed on
Bioanalyser for quality assurance. Libraries were then sub-
jected to 150 bp paired-end sequencing using the Illumina
MiSeq instrument.
Bioinformatics––data filtering and alignment
For all WGBS runs, internal controls showed greater than
95% of all reads were detected by the MiSeq to be ≥ Q30.
Just over 45 million reads passed filter for all samples. All
reads that passed filter from theMiSeq were then further as-
sessed throughFastQCv0.11.3 for standard quality control.
Reads were trimmed with Trimgalore version 0.4.4 with a
minimumquality cut off of 28 bp and aminimum length cut
off of 30 bp. Following adapter trimming, all reads below a
QC threshold of 30 were discarded. Mapping and methyla-
tion calls were done using BSMAP v2.42 (28).
For MeDIP runs, TrimGalore software was used
to http://www.bioinformatics.babraham.ac.uk/projects/
trim galore/) (29) to remove the custom adapters of the
paired-end sequences, and 20 additional nucleotides from
each 3-prime end, due to the specific requirements of the
sequencing kit. The custom adapters were GCCAAT,
CAGATC, CTTGTA and AGTCAA, for both read files
of sample ‘HepG2’, ‘HepG2-replicate’, ‘Hepatocyte’ and
‘Hepatocyte-replicate’, respectively. The NC 012920.1
mitochondrial genome was used as the reference genome
for the alignment that was done by bowtie2 software
(30). The same software was used to perform the paired-
end alignment and obtained SAM files. After replacing
‘NC 012920.1’ by ‘chrM’, sorted BAM files were generated
with samtools (31) and the indexes were obtained of each
file using the command index. Next, the BAM files were
uploaded into the Integrative Genome Viewer (IGV)
software to obtain the read profile of each sample and their
plots and calculated the differential methylation across
the mitochondrial chromosome by using the default pa-
rameters of the MEDIPS R package (32). Briefly, we used
chromosome M of the ‘BSgenome.Hsapiens.UCSC.hg38’
library as a reference genome and fixed a P value = 1e-3
as a maximum of stacked reads per genomic position,
extending all reads to a length of 300 nucleotides according
to the given strand information and dividing the genome
into adjacent windows of length = 100 nucleotides.
Noise filtering ofmitochondrial DNAmethylation sequencing
data
Conventional methods used for assessing bisulfite conver-
sion efficiency of nuclear DNA (33), which require spiking
samples with  DNA, were unsuccessful for sequencing of
mtDNA (data not shown). Hence, in order to assess the
quality of the sequencing reads, apart from standard read
filtering methods described above, a 100% unmethylated
plasmid DNA (ThermoFisher Scientific Cat. No SD0021)
sample was processed and sequenced alongside the samples
of interest. The amount of potential incorrect methylation
calls was assessed from these data to determine the thresh-
old of sequencing reads that need to be considered for avoid-
ing potential false positive methylation calls. The following
formula was used:
False PositiveRate =
[(
#methylated cytosines in plasmid genome
total # cytosines in plasmid genome
)
∗ 100
]
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From this analysis, we found that including data points
under the threshold of 10 reads and all cytosines with
methylation levels under 9% considerably increased the false
positive detection of methylation, decreasing the accuracy
to <97%. Therefore, for all datasets, all sites with coverage
of<10 reads as well as all sites withmethylation levels under
9% were removed. This ensured that the methylation calls
from the data are at least 98.95% accurate.
Methylation calculations
Descriptive Statistics on the global patterns of methyla-
tion across the four cell lines was conducted in order to
compare between cell lines. The following formulas were
used to determine the methylation ratio at individual cy-
tosines, methylation index (MI) and proportion of methy-
lation across the mitochondrial genome:
MethylationRatio =
[
#of reads identified asmethylated forCpN site
total # of reads aligned to thatCpN site
]
Methylation IndexOver aRegion =
[(
sumof allmCpN sites
total # of CpN sites
)
∗ 100
]
Proportion of Methylation =
[(
#of methylated cytosines
16597
)
∗ 100
]
Non-parametric, paired and unpaired Wilcox T-test was
used to calculate significant differences between mean
methylation of functionally relevant genomic regions be-
tween cell types.
Methylated DNA immunoprecipitation
A total of 1.2 g of mtDNA per reaction was extracted
as outlined in the ‘Mitochondrial DNA Extraction’ section
above fromHepG2 and hepatocyte cells. Cell lines were pro-
cessed in technical duplicate using the Auto MagMeDIP
Kit (Diagenode #C02010013) as per instructions. Briefly,
extracted mtDNA was sonicated, quantified and assessed
for fragment size and quality via Qubit and BioAnal-
yser. Immunoprecipitation was conducted by pre-set pro-
tocols on the IP-Star Compact robot (Diagenode) that
performed the necessary antibody incubation and wash-
ing steps required. Library preparation for sequencing of
the MeDIP output mtDNA was then performed using the
ACCEL-NGS Methyl-Seq DNA Library Kit (Swift Bio-
science #30024) as per manufacturer instructions.
RNA interference-mediated knockdown of DNMT enzymes
Small interfering RNAs (siRNAs) were introduced into
MCF10A cells by transfection using the Lipofectamine®
RNAiMAX Reagent (Invitrogen) according to the manu-
facturer instructions. Cells were transfected with 100 nM
of the following human ON-TARGETplus SMARTpools
(Dharmacon): DNMT1 (ON-TARGET plus SMARTpool
siDNMT1, L-004605-00-0005), DNMT3a (ON-TARGET
plus SMARTpool siDNMT3a, L-006672-01-0005),
DNMT3b (ON-TARGET plus SMARTpool siDNMT3b,
L-006395-00-0005) or ON-TARGET plus non-targeting
pool (D-001810-10-05) that was used as a negative control.
Cells were harvested 96 h post-transfection and protein
was extracted to validate the silencing with western blot.
Western blot analysis of DNMT enzymes
Whole cell protein lysates were extracted using ice-cold
RIPA buffer supplemented with protease inhibitors. Pro-
tein (50g) was subjected to SDS-PAGE followed by
immunoblotting. Primary antibodies against DNMT3a
(ab13888, 1:500) and DNMT3b (ab13604, 1:500) were
obtained from Abcam. Monoclonal antibodies against
DNMT1 (MAB0079, 1:1000) and -actin (Clone C4,
1:1000) were obtained from Abnova and MP Biomedicals,
respectively.
Relative protein levels were quantified by ImageJ (https:
//imagej.nih.gov/ij/). The relative intensity was calculated
for eachDNMTbandwith respect to the siControl and nor-
malized to the relative intensity of actin in each sample.
Mitochondrial DNA content assessment
Whole cell DNA and RNA extractions were performed us-
ing the All Prep DNA/RNAMini Kit (Qiagen, REF80204)
according to manufacturer instructions. The mitochondrial
DNA content in each cell type was determined using qPCR
on whole cell DNA extractions. Primers specific to the mi-
tochondrial genome, Forward Primer (5′-GCTCAACACC
CACTACCTAAA-3′), Reverse Primer (5′-TGATCTGA
CGCAGGCTTATG-3′) as well as primers specific to nu-
clear encoded geneGAPDH,Forward Primer (5′-CCCTTC
ATACCCTCACGTATTC-3′), Reverse Primer (5′-CCAT
TCTGTCTTCCACTCACTC-3′) were used to amplify the
whole cell DNA extraction. The mtDNA content of the ex-
traction was assessed by comparing the fold change in ex-
pression of mitochondrial genome versus nuclear genome
using the Ct method.
mRNA expression analysis
Following cDNA synthesis from the above RNA extrac-
tions, relative enrichment of mRNA expression of mito-
chondrial encoded geneswas assessedwith qPCRusing pre-
viously published primers (see Supplementary Table S1).
GAPDH, Forward Primer (5′AACGGGAAGCTTGTCA
TCAA-3′), Reverse Primer (5′TGGACTCCCACGACGT
ACTCA-3′), was used as housekeeping gene for breast
cell types. SFRS4, Forward Primer(5′-GGCTACGGGA
AGATCCTGGA-3′), Reverse Primer (5′-TGCATCACGC
AGATCATCAA-3′), was used as housekeeping gene for
liver cell types (34). In order to compare mRNA expression
between cell lines, mRNA expression was normalized to the
mtDNA content in each cell in order to account for vastly
differing mitochondrial DNA content between cell types:
GeneExpressionNormalized
= Ct mRNA Expression relative to housekeeping gene
Ct Mitochondrial DNA amount relative to nuclear DNA
RESULTS
Development of NGS methodology for high-resolution
DNA methylation analysis specifically for the mitochondrial
genome
To investigate genome-wide mtDNA methylation patterns
at single base pair resolution in human normal and can-
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cer cell lines and tissues, we aimed to optimize the method
that combines bisulfite conversion with NGS. To this end,
the mtDNA enrichment achieved from the extraction pro-
tocol was confirmed by qPCR analysis using mitochondrial
and nuclear specific primers (Figure 1A). Based on previ-
ous studies, mtDNA was initially extracted from HepG2
cells and linearized with restriction enzyme BamHI in order
to avoid bisulfite conversion inefficiency as previously de-
scribed (24). This was then followed by deep sequencing us-
ing theMiSeq platform. The degree of methylation detected
at each cytosine position was compared to the sequencing
depth achieved for that position (Figure 1B). In line with
previous reports, the data showed that only small methy-
lation values had high sequencing depth and that reads
exhibiting higher methylation values had low sequencing
depth (23). Moreover, the ratio of sequencing reads (not
shown) which aligned to the H-strand compared to the L-
strand was also uneven (0.08), suggesting some amplifica-
tion bias. However, mtDNA that was fragmented mechan-
ically prior to bisulfite modification and sequencing, elimi-
nated this strand bias (ratio = 1.16) (Figure 1C). Further-
more, the cells that were sonicated prior to sequencing also
produced far better coverage (Figure 1E). Hence, all further
samples were fragmented before bisulfite modification and
subsequent sequencing.
To ensure quality methylation calls, 100% unmethylated
plasmid DNA was processed and sequenced simultane-
ously alongside the mtDNA samples (Figure 1F). When all
methylation calls with <10× coverage and <9% methyla-
tion were excluded, 378 cytosines remained false positive
out of a potential 24 182 cytosines. Hence 98.44% accuracy
in methylation calls can be achieved with minimum 10×
coverage and a detection threshold of 9% methylation. All
reads not matching this threshold criteria were excluded as
background noise (see ‘Materials and Methods’ section).
To further confirm that these results are not the conse-
quence of bisulfite conversion-related false positives, mito-
chondrial DNA of HepG2 cells and primary hepatocytes
were processed via a bisulfite-free method to confirm that
the mtDNA is methylated. MeDIP-seq assay performed on
technical replicates of two cell lines also showed that the mi-
tochondrial genome was globally methylated, hence com-
plementing the WGBS data (Supplementary Figure S1A).
The results indicate this stringent approach allows ade-
quate investigation of mtDNA methylation at single base
pair resolution that accounts for both CpG and non-CpG
methylation.
Mitochondrial DNA within normal and cancer liver cells ex-
hibit significantly different methylation patterns that are pri-
marily in a non-CpG context
In order to establish baseline methylation patterns within
the mitochondrial genome, normal liver cells derived from
primary human liver (hepatocytes) and liver cancer cells
(HepG2) were assessed first. Globally, in both cases, the L-
strand displayed a higher degree and frequency of methyla-
tion compared to the H-strand (Figure 2A and B). Hepa-
tocytes had 37% of all cytosines were methylated, whereas
HepG2 had 44% of their mitochondria methylated (Figure
2C). Interestingly, in contrast to nuclearDNA, a substantial
amount of methylation in the hepatocyte and HepG2 mito-
chondrial genome was detected in CpT, CpC and CpA con-
texts. The highest frequency of methylation (around 30%)
was detected within a CpT and CpC dinucleotide context,
whereas methylation of CpG sites had the lowest methy-
lation frequency (12% and 5%, respectively) (Figure 2C).
A striking difference in methylation was observed across
tRNA encoding regions. Specifically, hepatocytes are com-
pletely devoid of methylation on the L-strand within tR-
NAs which carry the amino acids arginine and lysine (Arg
and Lys MI = 0%) (Figure 2D); however, these same re-
gions are methylated in HepG2 cells (MI = 11.4%) (Figure
2D). Significant differences in mean methylation across al-
most all gene encoding regions in both strands of HepG2
was detected compared to hepatocytes (P value < 0.001;
Figure 2E). In addition, the distribution of methylation val-
ues across the displacement loop in each cell type was com-
pared since this region contains multiple promoters and
functionally relevant transcriptional start sites.Hepatocytes
showed a bimodal distribution of methylation values in-
dicating both highly and lowly methylated regions across
the D-Loop, whereas HepG2 showed a right skewed dis-
tribution indicating the D-Loop is mostly highly methy-
lated (Figure 2F). Methylation across the L-strand pro-
moter region (392–435 bp) was compared to the level of
ND6mRNAexpression in each cell type. Finally, the higher
methylation across the L-strand promoter region detected
in HepG2 was associated with lower expression of ND6
mRNA compared to hepatocytes (Figure 2G).
To ensure biological relevance of mtDNAmethylation in
the disease context, primary tissue resections of normal liver
and hepatocellular carcinoma samples were also examined
(Supplementary Figure S2). Similar to the cell line samples,
significant differences (P value < 0.001) in mean methyla-
tion of both global and some gene-encoding regions across
both strands was observed (Supplementary Figure S2A and
C). Both primary samples showed a bimodal distribution of
methylation values across the D-Loop, however in line with
methylation patterns observed in cell line samples (Figure
2D), this distribution was slightly skewed toward the right
in tumour cells (Supplementary Figure S2B).
Together these results show that specific mtDNA methy-
lation profiles across biologically relevant genomic regions
can be observed among different normal and cancer cell
types.
Baseline mitochondrial methylation patterns of normal and
cancer breast cell lines differ significantly
To test the generality of mitochondrial genome methyla-
tion, baseline mtDNA methylation patterns were next ex-
amined in an independent cell type. MtDNA isolated from
normal mammary epithelial cells (MCF10A) and breast
cancer cells (MCF7) were assessed and compared. Similar
to the liver context, globally in both cases, the L-strand
displayed a higher degree and frequency of methylation
compared to the H-strand (Figure 3A and B). MCF10A
had 43% of the entire mitochondrial genome methylated,
whereas MCF7 had 38% of their mitochondria methylated
(Figure 3C). In contrast to nuclear DNA, and much like
what was observed in liver cells, a substantial amount of
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Figure 1. Mitochondrial DNA sequencing requires method adjustments. (A) Raw amplification cycles of mtDNA enrichment assessed with qPCR of a
mitochondrial specific genomic region compared to nuclear specific GAPDH genomic region (left panel). Relative fold enrichment of mtDNA to nuclear
DNA (2−Ct) for HepG2 mtDNA extractions is indicated (right panel). The lack of nuclear DNA enrichment confirms the quality of mtDNA extrac-
tion. (B) Cytosine methylation compared to sequencing read depth (left panel) of HepG2 mtDNA which was digested with 2U of BamHI overnight at
37◦C and visualised on agarose gel (right panel). (C) Cytosine methylation compared to sequencing read depth (left panel) of HepG2 mtDNA that was
fragmented via sonication (100–7000 bp) and visualized on agarose gel (right panel). (D) HepG2 sonicated mtDNA (left panel) and bisulfite modified
mtDNA (right panel) was assessed on the BioAnalyser to ensure sonication was efficient and that modified mtDNA produced the standard expected
curve. (E) Average number of reads aligning to the mitochondrial genome per 1000 bp. HepG2 sample that was sonicated prior to sequencing showed an
improvement in coverage compared to the BamHI-treated HepG2 sample. (F) A 100% unmethylated plasmid DNA control was processed and sequenced
alongside mtDNA samples to ensure an appropriate false positive threshold can be used for data analysis. The X-axis represents the genomic position of
the plasmid genome (48 kb). The Y-axis represents the methylation value detected at each cytosine. The dots represent the 1.56% false detection rate.
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Figure 2. Baseline patterns of the mitochondrial methylome in normal and cancer liver cells. (A and B) MtDNA isolated from hepatocytes and liver cancer
cells (HepG2) that was sequenced using the NSGMiSeq platform as described in Figure 1. The circular plot represents genomic position (1–16 kb) of all
methylated cytosines with respect to sequence order. Each segment of the circle represents a separate functionally relevant region, tRNA, rRNA, gene or
D-Loop. TheY-axis indicating that methylation level is represented on the left-hand side of the D-Loop segment. The large outer ring displays methylation
at each cytosine within the H-Strand, whereas the large inner ring displays methylation at each cytosine on the L-Strand. Thin inner bands indicate the
genomic position of all cytosines within the H-Strand and L-Strand sequence. Global mtDNAmethylation patterns differ between hepatocytes and cancer
cells and are also strand specific. (C) Summary statistics of the frequency of mitochondrial mCpN context in liver cells. (D)Methylation Index across tRNA
encoding regions in liver cancer versus normal cells. Each horizontal segment compares the MI within tRNAs that have been grouped according to the
amino acid they carry (acidic, basic, aromatic or hydrophobic). The left panel indicates MI across H-Strand and right panel indicates MI across L-Strand.
(E) Comparative boxplots indicating significant (P < 0.001) difference of mean methylation across gene encoding regions of normal versus cancer cells
in each strand. (F) Density plot of the distribution of methylation values along the D-Loop region. (G) Relative ND6 mRNA expression normalized to
mtDNA amount compared with methylation index across the LSP. High LSP methylation associates with low ND6 expression.
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Figure 3. Baseline patterns of the mitochondrial methylome in normal and cancer breast cells. MtDNA was sequenced using the NSG MiSeq platform.
The circular plot represents genomic position (1–16 kb) of all methylated cytosines with respect to sequence order. Each segment of the circle represents
a separate functionally relevant region, tRNA, rRNA, gene or DLoop. The Y-axis indicating methylation level is represented on the left-hand side of the
D-Loop segment. The large outer ring displays methylation at each cytosine within the H-Strand whereas the large inner ring displays methylation at
each cytosine on the L-Strand. Thin inner bands indicate the genomic position of all cytosines within the H-Strand, L-Strand sequence. Global mtDNA
methylation patterns differ between these cell types and are also strand specific. (A) Normal breast epithelial cells (MCF10A); (B) Cancer epithelial cells
(MCF7); (C) Summary statistics of the frequency of mitochondrial mCpN context in liver cells and (D) Methylation Index across tRNA encoding regions
in breast cancer versus normal. Each horizontal segment compares the MI within tRNAs that have been grouped according to the amino acid they carry
(acidic, basic, aromatic or hydrophobic). The left panel indicates MI across H-Strand and right panel indicates MI across L-Strand. (E) Comparative
boxplot indicating significant (P < 0.001) difference of mean methylation across gene encoding regions of normal versus cancer cells in each strand. (F)
Density plot of the distribution of methylation values along the D-Loop region. (G) Relative ND6 mRNA expression normalized to mtDNA amount
compared with methylation index across the LSP. High LSP methylation associates with low ND6 expression
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methylation in the MCF10A and MCF7 mitochondrial
genome was detected in CpT, CpC and CpA contexts.
Again, the highest frequency of methylation was detected
within a CpT or CpC dinucleotide context, whereas methy-
lation ofCpG sites was the least frequentlymethylated dinu-
cleotides (12% and 10%, respectively) (Figure 3C). In breast
cells a different pattern of tRNAmethylation was observed
compared to liver cells. On the H-strand of breast cancer
cells (MCF7) (Figure 3D), methylation in tRNA encoding
regions, which carry the amino acids arginine, lysine, as-
paragine and glutamine, is almost completely lost (MI =
0.29%) compared to normal breast (MCF10A) cells (MI =
8.84%) (Figure 3D). The distribution of methylation values
across the displacement loop in each cell typewas compared
since this region contains multiple promoters and function-
ally relevant transcriptional start sites. MCF7 exhibited a
bimodal distribution of methylation values indicating the
presence of both highly and lowlymethylated regions across
the D-Loop, whereas MCF10A showed a right skewed dis-
tribution, consistent with high level methylation in the D-
Loop (Figure 3F). Methylation levels across the L-strand
promoter region (392–435 bp) were then compared with the
level of ND6 mRNA expression in each cell type. Higher
methylation across the region detected in MCF10A coin-
cided with lower expression of ND6 compared to MCF7
(Figure 3G), these findings were consistent with those ob-
served in liver cells.
To investigate concordance of baseline methylation pat-
terns among cell types, additional normal liver (HepaRG)
and normal breast (HMEC) cell lines were subjected to
mtDNA methylation profiling. Significant differences in
mean methylation of both global as well as some gene en-
coding regions across both strands was observed between
HMECandMCF10A cells (Supplementary Figure S2D–F)
as well as hepatocytes and HepaRG cells (Supplementary
Figure S2G–I).
Together these results provide further evidence to the gen-
erality of previously mentioned methylation patterns and
confirm the methylation patterns are cell type specific.
DNMT3B, DNMT3A and DNMT1 are involved in modulat-
ing mtDNA methylation
Since multiple DNMTs have previously been detected in the
mitochondria by various independent studies (10,17,20,21),
it was important to assess the dependence of mtDNA
methylation patterns on different DNMT enzymes. Thus,
the impact of knockdown of DNMT1, DNMT3A and
DMT3B on mtDNA methylation was assessed using a
siRNA approach. Global cellular protein levels of each en-
zyme were depleted individually in MCF10A cells (Supple-
mentary Figure S3) and was followed by mtDNA methy-
lation analysis. Silencing of all three DNMT enzymes re-
sulted in markedly reduced levels of cytosine methylation
globally across the MCF10A mitochondrial genome com-
pared to the control cells (Supplementary Figure S4).
The degree and frequency of methylation were especially
affected in the DNMT3B silenced cells (Figure 4A and B)
with the L-strand most heavily affected (Figure 4A and B),
therefore the impact of DNMT3B knockdown on mtDNA
methylation was analysed in further detail. Methylation be-
tween DNMT3B knockdown and control cells showed the
L-strand in both cases displayed a higher degree and fre-
quency of methylation compared to the H-strand (Figure
4A). Significant decreases (P value < 0.001) were observed
in global methylation in the knockdown cells as well as
within gene encoding regions on both strands (Figure 4C
and E). The distribution of methylation values across the
displacement loop in the knockdown cells was also ob-
served to be markedly lower than in control cells (Fig-
ure 4D). To assess potential functional impact of the ob-
servedmtDNAmethylation loss, mRNA expression of a set
of mitochondrial genes was analysed in DNMT3B knock-
down cells. A drop in methylation in the D-Loop region in
DNMT3B knockdown cells, which accounts for a drop in
methylation across all promoter regions, resulted in higher
mRNA expression of the genes COX1, COX3,ND4,ND4L
and ND5 (Figure 4G). Furthermore, similar to previous
observations, the drop in global methylation induced by
DNMT3B knockdown resulted in reduced methylation of
the LSP and this was found to be concomitant with an in-
crease in mRNA expression of the ND6 gene (Figure 4H).
Since knockdown experiments implicated a potential role
for DNMTs in mtDNA methylation, whether DNMT en-
zymes are present in mitochondria was further explored
with confocal microscopy. Analysis of 2D images sug-
gest small amounts of all three DNMT1, DNMT3A and
DNMT3B may be co-localized in both MCF7 and HepG2
cells (Supplementary Figure S4); however, additional assays
such as z-stack imaging are needed to confirm and consoli-
date these data.
Together these results suggest that DNMT1, DNMT3A
and DNMT3B enzymes may be associated with the ob-
served baseline methylation patterns of the mitochondrial
genome and there may be a link between mtDNA methy-
lation and gene expression as is the case in the nuclear
genome.
DISCUSSION
The present study for the first time combines appropriate
stepwise methodology for quantitatively assessing genome-
wide mtDNA methylation at both CpG and non-CpG
methylation sites with base-pair resolution. This method-
ology has revealed human mitochondrial genomes can be
extensively methylated. Results show that themethylation is
cell type specific occurs predominantly in a non-CpG con-
text and is more heavily present on the L-strand than the
H-Strand. MtDNA methylation can be modulated by de-
creasing global protein levels of DNMT1, DNMT3A and
DNMT3B enzymes, suggesting an association of these en-
zymes with mtDNA methylation. A potential functional
relevance of this methylation is suggested by the observed
association between mtDNA methylation levels within the
displacement loop region and mRNA of relevant genes en-
coded on the mitochondrial DNA. Considering the differ-
ent mitochondrial methylome patterns observed in the nor-
mal and cancer cells examined, this study suggests impor-
tant implications for the role of mtDNA methylation in tu-
morigenesis.
There are three crucial steps in methodology that is
unique and specific for WGBS of mtDNA in this study
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Figure 4. Silencing DNMT3B modulates mitochondrial DNA methylation concomitant to expression changes of mitochondrial transcripts. (A) MtDNA
methylation in MCF10A cells exposed to a 96-h treatment of DNMT3B siRNA compared to control. A global drop in methylation ratio is observed for
H and L strand methylation in DNMT3Bsi treated cells. (B) Whole cell protein was assayed for relative amounts of DNMT3B via western blot to confirm
assay efficiency. (C) Comparative boxplot indicating significant (P< 0.001) difference of mean methylation across gene encoding regions of control versus
knockdown treated cells in each strand. (D) Paired Wilcox t-test showing significance of the global drop in methylation between control and treated cells
(P < 0.001). (E) Density plot of the distribution of methylation values along the D-Loop region. (F) Whole cell protein of repeat experiment assayed for
relative amounts of DNMT3B via western blot to confirm efficiency. (G) Relative mRNA expression normalized to mtDNA amount compared of genes
encoded on the H-strand. Treated cells show an increase in gene expression compared to control. (H) Relative ND6 mRNA expression normalized to
mtDNA amount compared with methylation index across the LSP. High LSP methylation associates with low ND6 expression.
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(Supplementary Figure S5). These are (i) the separation
of mtDNA from nuclear DNA, (ii) removal of excess pro-
tein via phenol-chloroform and (iii) finally shearing of the
mtDNA to ensure no coiled or secondary structures remain
prior to bisulfite sequencing. The following describes how
methodology may be a key contributor to underestimation
of mtDNA in previous reports.
One of the key issues pertaining to sequencing mtDNA
for methylation analysis is in understanding the intrinsic
differences ofmtDNA function and structure as well as how
these differences require adaptation of existing method-
ologies which have evolved with a primary focus on nu-
clear DNA and CpG methylation. Liu et al., for instance,
showed that the mtDNA needs to be linearized prior to
methylation analysis with pyrosequencing to avoid overes-
timation of methylation values owing to inefficient bisulfite
conversion (24) caused by the coiled, circular structures of
mtDNA. Results from this study concur with previous find-
ings since in all cell lines analysed via pyrosequencing, lin-
earized mtDNA via sonication showed lower methylation
levels compared to unfragmented, circular mtDNA (data
not shown). In addition, pyrosequencing detected lower
amounts of mtDNA methylation than those detected by
NGS (Supplementary Figure S1C). Since global methyla-
tion was observed in both methylation results from NGS
andMeDIP-seq data of two different cell lines (Supplemen-
tary Figure S1A), it is likely that pyrosequencing may un-
derestimate cytosinemethylation ofmtDNAdue to its CpG
nucleotide bias (Supplementary Figure S1C). One explana-
tion for the discrepancy between pyrosequencing and NGS
results can be attributed to the previously established notion
that standard pyrosequencing assays are biased towards
CpG methylation (35,36). This is especially relevant to the
mitochondrial genome where the sequence is heavily dis-
persed with repetitive cytosine nucleotides (n> 3) through-
out the genome.Hencemethodology that adequately allows
assessment of both CpG and non-CpG methylation is es-
sential for investigating mtDNA methylation; this may be
a possible explanation for previous reports that have con-
cluded low or no mitochondrial methylation (6).
The complimentary bisulfitemethylation data (Figure 2A
and B) and MeDIP data (Supplementary Figure S1A) ob-
served in this study is in line with previous reports that
comprehensively showed cytosine methylation within mi-
tochondrial genomes to be present across 39 pre-existing
datasets spanning different human cell and tissue types
(37). Although our results concur with conclusionsmade by
Ghosh et al., it should be noted that since the paper was first
published, a series of methodological processing required
to address bisulfite conversion efficiency that is unique for
mtDNAhas been reported (23,24). Thismay be another po-
tential factor that has lead to the idea that mtDNA is gen-
erally lowly methylated. Pre-existing WGBS datasets were
not produced with experimental considerations unique to
mtDNA in mind. Hence assessing mtDNA methylation in
these databases, although a viable option for exploratory
analysis, may underestimatemtDNAmethylation levels and
this should be considered for future studies (37).
Accurate fragmentation is a key technical adaption that
needs to be optimized in order to ensure high quality, re-
liable methylation reads from sequencing data. Recently,
Mechta et al. concluded that secondary structures of mito-
chondrial DNA may have caused hindrance in the bisulfite
conversion step leading to false positive methylation values
(23). In concordance, results from this study further demon-
strate that fragmentation of mtDNA is required for opti-
mal mtDNA accessibility for accurate bisulfite conversion
and sequencing (Figure 1). This was further consolidated
by the high correlation (R2 = 0.97) observed between bio-
logical replicate data (Supplementary Figure S1B). Accessi-
bility needs to be addressed when considering mtDNA for
bisulfite sequencing due to the highly coiled form it exists
within cells (38). When cells were treated with BamHI and
sequenced (Figure 1B), the data showed an almost exact
match to the ‘read depth versus methylation value’ patterns
obtained byMechta et al. (23) and we concur this was most
likely due to hindrance toward bisulfite conversion from
secondary structures post linearisation (23). However, when
mtDNA was fragmented through sonication a more even
distribution of methylation values and sequencing depth
was achieved (Figure 1C). One of the pitfalls of using son-
ication for fragmentation is the lack of control in obtain-
ing fragment sizes. Each cell line had to be individually
optimized (Figure 1D) through a rigorous process of trial
and error until an ideal range of fragments were observed
on agarose gel (∼100–7000 bp) and these size ranges were
then confirmed with BioAnalyser. Since these fragments
then underwent a further strenuous process of bisulfite con-
version, it is possible that a number of fragments (espe-
cially fragments within 100–200 bp size) would have been
more vulnerable to degradation, making them impossible
to be incorporated in the library preparation stage. Indeed
those mitochondrial DNA samples which were sonicated
to the point where all fragments were within 100–200 bp
range did not produce successful libraries (data not shown).
Hence although not perfected, fragmentation via sonication
can overcome secondary structure obstructions to bisul-
fite conversion. The data presented in this study have been
validated via a secondary non-bisulfite dependent method
(Supplementary Figure S1A) and shown to be reproducible
(R2 = 0.97) through cell line biological replicates (Supple-
mentary Figure S1B). This line of evidence provides support
that the data is unlikely to be false positive results.
Another key step in the methodology that is crucial for
consideration is the phenol-chloroform extraction that im-
mediately followed extraction of the crude mitochondrial
DNA pellet (see ‘Materials and Methods’ section). Us-
ing crystal structure imaging, it has been previously shown
that the mtDNA transcription factor TFAM binds to both
H-Strand promoter, as well as non-specific mtDNA re-
gions, and imposes U-turn shapes on the mtDNA. Hence,
transcription factor binding encourages compaction and
packaging of mtDNA molecules (38). This combined with
the difficulty observed in HepG2 mtDNA double diges-
tion with restriction enzymes BamHI and EcoRI (data not
shown), we hypothesized that some protein–DNA interac-
tions may have remained intact during the crude mtDNA
extraction protocol. Since phenol-chloroform is a technique
used to separate nucleic acids from proteins and lipids
(39,40), it was added as a final step in the extractionmethod.
After this step was added to the protocol, complete frag-
mentation of the mtDNA in subsequent steps was easier as
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observed by number of sonication cycles required and vi-
sualization on agarose gel (data not shown). Hence there is
a chance mtDNA bound transcription factors, and/or any
restriction enzymes used for linearization, remain and en-
courage compaction of mtDNA following extraction meth-
ods that have not undergone phenol-chloroform clean up.
Hence further investigation is required to confirm results
from any reports (26,41) of mtDNA methylation that have
relied on restriction enzyme digestion alone as this may
be a point of hindrance in efficient bisulfite conversion of
mtDNA. These findings show that methodology for bisul-
fite sequencing needs to be specifically adapted for mito-
chondrial genomes.
Since the D-Loop consists of promoter regions and is
responsible for controlling mtDNA replication, we con-
sidered whether the frequency distribution of methylation
within this region differs in normal and cancer contexts. A
striking shift from the bimodal distribution of methylation
frequency in normal liver cells was observed in liver cancer
cells, which was strongly right skewed (Figure 2D). A sim-
ilar but less pronounced pattern was also observed in pri-
mary liver and liver tumour resections (Supplementary Fig-
ure S2A–C). However, a different distribution of D-Loop
methylation was observed in breast cancer and normal cells
(Figure 3F). MtDNA content and cancer have been pre-
viously implicated in disease prognosis. For example, low
mtDNA content was found to be associated with better sur-
vival (42) and treatment outcomes (43) for breast cancer pa-
tients, whereas lowmtDNA content in liver has been associ-
ated with higher risk of developing non-alcoholic fatty liver
disease, a precursor to cancer development (44). Since the
D-Loop region is involved in mtDNA replication, whether
D-Loop methylation determined by this study (Figures 2F,
3F and 4D) has direct regulatory consequences for mito-
chondrial replication should be investigated further. The
functional consequences of this could mean a cell type spe-
cific layer of regulation concerning mtDNA replication that
has remained unexplored.
Because MtDNA is known to insert into the nuclear
genome, resulting in ‘nuclear DNA sequences of mitochon-
drial origin’ (NUMTs), the presence ofNUMTs in some an-
alytical procedures may generate misleading results (6,23).
It is estimated that there are between 1000 and 10 000 copies
of mtDNA in each mammalian cell (45); hence, the prob-
ability of identical sequences in the nuclear genome being
amplified when mtDNA is the target sequence is extremely
low due to the vast excess ofmtDNA (6). AlthoughmtDNA
enrichment was confirmed using qPCR, to avoid any com-
plication, data from this study was aligned to the human
nuclear genome (Human Genome Assembly GRCh38.p12,
June 2018) as well as to the mitochondrial genome alone
(revised Cambridge Reference Sequence NC 012920, June
2018). Any reads that aligned to both were excluded to en-
sure only those reads that uniquely mapped to mtDNA
were considered in the analysis. Therefore, the presence
of NUMT sequences is highly unlikely to contribute to
mtDNA methylation levels and patterns observed in this
study.
Previous work investigating non-CpG methylation in the
nuclear genome has shown a conservation of methylation
context. The trend observed in nuclear genome, i.e. mCpG
> mCpA > mCpT > mCpC (36), has been attributed to
the observed patterns being non-random and hence bio-
logically significant. Similarly in this study, distinct trends
in the frequency of methylation at each dinucleotide, i.e.
mCpC>mCpA /mCpT>mCpG, is largely conserved in all
cell types. Further studies are warranted to examine the po-
tential biological significance of the consistent occurrence
of non-CpG methylation detected in mtDNA. In the nu-
clear genome, unlike CpG methylation, non-CpG methy-
lation largely occurs asymmetrically and this has been at-
tributed to its acute regulation in response to environmental
stimuli/stressors. It has also been shown to regulate the ex-
pression of specific genes, in particular PGC-1a (35) which
is involved in mitochondrial function and biogenesis. In the
nuclear genome, characteristic areas of the genome, such as
gene promoter regions, are often aberrantly hypo- or hyper-
methylated in cancer versus normal cells and this has been
directly linked to transcriptional regulation of gene expres-
sion (46). Likewise, this study has shown a similar associa-
tion where higher average promoter methylation of the L-
strand has been concomitant with lower expression of ND6
between different cell types (Figures 2E, 3E and 4E). This
suggests the detected methylation may play a role in strand
specific regulation of gene expression. These results concur
with previous investigations where gene expression was as-
sociated with induced promoter methylation within GpC
dinucleotides (22). It should be noted that GpC methyla-
tion from the previous study has been reported as part of
the CpN methylation in the present study. It is also note-
worthy that in mtDNA, unlike in the nuclear genome, one
promoter region such as the Origin of replication (100–441
bp) has been identified to regulate multiple genes (3,5). Pre-
vious reports have shown a link between the expression of
specific genes, such as ND1, to be associated with induced
GpC methylation within specific promoters such as HSP2
(22). To further emphasize this, strand specific methylation
of CpG and adjacent CpN sites has been shown across a
known transcription factor binding site (523–550 bp) of the
mitochondrial genome in Supplementary Figure S4 (47).
The complex relationship between multiple H-strand pro-
moters and origins of replication in the D-Loop as well as
varying distributions ofmethylation in theD-Loop between
cell types observed in this study should be investigated fur-
ther to determine any functional links to transcription of
genes encoded on the H-strand. The asymmetry of non-
CpG methylation has previously been attributed to its high
response to environmental stimuli (36). In addition, mito-
chondria are known to be highly responsive to changing cel-
lular conditions as part of many of their physiological func-
tions such as maintaining cellular energy demands. Hence,
it can be postulated that the detected mtDNA methylation
could play a role in regulation of specific genes in a transient
manner with respect to immediate cellular demand.
Another important finding from this study is that the
methylation may be modulated by global cellular DNMT
enzymes (Supplementary Figure S3). It is also notewor-
thy that DNMT3B was the enzyme that severely impacted
the global frequency and amount of mtDNA methylation
in normal breast cells (Figure 4). It should be noted that
a wide variety of nuclear encoded genes are known to
have direct, functional effects on mitochondrial processes
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as well as mitochondrial DNA compaction and transcrip-
tion (48). The effects of DNMT knockdown on these nu-
clear encoded genes and any potential consequential effects
on the observed changes in mtDNAmethylation cannot be
ruled out. Co-operative maintenance of DNA methylation
by the DNMT family of enzymes in the nuclear genome
has been previously well characterized (49). However, lit-
tle is known about the consequences of aberrant overex-
pression of DNMT3B in particular that has been reported
for a number of malignancies including breast cancer (50)
and colorectal cancer (51,52). Due to its high relevance in
disease, there is a need for a better understanding of the
complex interplay between the DNMT family of enzymes
and how they may be involved in modulating mitochon-
drial DNAmethylation. The complex nature of the nuclear-
mitochondrial crosstalk, and how methylation of the two
genomes plays a role (48) is another area of future investi-
gation.
In summary, the present study demonstrates, for the first
time via NGS-based bisulfite sequencing, that the mito-
chondrial genome is heavily methylated with predominant
non-CpG methylation and that this methylation is associ-
ated with multiple DNMT enzymes. Furthermore, the re-
sults show that mtDNA methylation patterns are cell type
specific and that they may be functionally linked to mi-
tochondrial gene expression. Importantly, this study high-
lights key methodological requirements for adequate as-
sessment of methylation within mitochondrial DNA. This
study implores the importance of adapting methodology to
allow assessment of both CpG and non-CpG methylation
for future investigations. Future efforts aimed at decipher-
ing the potential functional consequences and biological
variances of mtDNA methylation may prove to be highly
useful.
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